Schedule 13D ownership disclosure
MABVAX THERAPEUTICS HOLDINGS, INC.
Security class unavailable · CUSIP: 55414P504
Event date: 2018-02-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,208,904
- Percent of class
- 4.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-18-001896
- Form type
- SC 13D
- Filer
- Honig Barry C
- CIK
- CIK 1373203
- Filed
- Feb 13, 2018
- Reporting period
- Feb 12, 2018
- Description
- Schedule 13D beneficial ownership